BIOMARIN PHARMACEUTICAL INC·5

Feb 10, 9:46 PM ET

FUCHS HENRY J 5

5 · BIOMARIN PHARMACEUTICAL INC · Filed Feb 10, 2023

Insider Transaction Report

Form 5
Period: 2022-12-31
FUCHS HENRY J
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2022-04-29$62.41/sh+341$21,281144,094 total
Footnotes (1)
  • [F1]Represents shares acquired by the reporting person on April 29, 2022, pursuant to the issuer's Employee Stock Purchase Plan.

Documents

1 file
  • 5
    doc1.xmlPrimary

    FORM 5